Related Experiment Video
Updated: Jun 1, 2026

Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia
Gustavo Christofoletti1, Merlyn Mércia Oliani, Lilian Teresa Bucken-Gobbi
1Universidade Federal de Mato Grosso do Sul, Health and Biological Sciences Center, Campo Grande, MS, Brazil. gustavo_physio@yahoo.com.br
Introduction:
A significant benefit from physical activity has recently been described in some patients who suffer from neurodegenerative diseases.
Objective:
To assess the effects of physical activity on neuropsychiatric disturbances in demented patients and on the mental burden of their caregivers.
Methods:
Assisted by a public geriatric psychiatry clinical unit, we studied 59 patients with dementia. Patients were divided into three groups according to their diagnosis and level of physical activity. Data were assessed through a semi-structured interview. Patients were evaluated with the Neuropsychiatric Inventory, the Mini-Sleep Questionnaire and the Baecke Questionnaire. The data were statistically analyzed using the Mann-Whitney U test and linear regression, with the level of significance set at 5%.
Results:
Patients with Alzheimer's or vascular dementia who engaged in physical activity had fewer neuropsychiatric symptoms than those who did not. When compared to the control group, the caregivers of patients with vascular dementia who engaged in physical activity had a reduced burden.
Conclusion:
The regular practice of physical activity seems to contribute to a reduction in neuropsychiatric symptoms in dementia patients and to attenuate the burden of the caregivers of those patients.
Related Concept Videos
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
